Postoperative interleukin-8 levels are related to the duration of coronary artery bypass grafting surgery and predict in-hospital postsurgical complications

1. Moazzami K, Dolmatova E, Maher J, Gerula C, Sambol J, Klapholz M, et al. In-hospital outcomes and complications of coronary artery bypass grafting in the United States between 2008 and 2012. J Cardiothorac Vasc Anesth. 2017;31(1):19-25. DOI: 10.1053/j.jvca.2016.08.00810.1053/j.jvca.2016.08.008Open DOISearch in Google Scholar

2. Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, et al. Mechanisms of very late bioresorbable scaffold thrombosis: The INVEST registry. J Am Coll Cardiol. 2017;70(19):2330-44. DOI: 10.1016/j.jacc.2017.09.01410.1016/j.jacc.2017.09.014Open DOISearch in Google Scholar

3. Șerban R, Scridon A, Dobreanu D, Elkaholut A. Coronary artery aneurysm formation within everolimus-eluting bioresorbable stent. Int J Cardiol. 2014;177:e4-5. DOI: 10.1016/j.ijcard.2014.07.19710.1016/j.ijcard.2014.07.197Open DOISearch in Google Scholar

4. DiNicolantonio JJ, D’Ascenzo F, Tomek A, Chatterjee S, Niazi AK, Biondi-Zoccai G. Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol. 2013;168(3):1739-44. DOI: 10.1016/j.ijcard.2013.06.13510.1016/j.ijcard.2013.06.135Open DOISearch in Google Scholar

5. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381:629-38. DOI: 10.1016/S0140-6736(13)60141-510.1016/S0140-6736(13)60141-5Open DOISearch in Google Scholar

6. Piątek J, Kędziora A, Konstanty-Kalandyk J, Kiełbasa G, Olszewska M, Song BH, et al. Risk factors for in-hospital mortality after coronary artery bypass grafting in patients 80 years old or older: a retrospective case-series study. PeerJ. 2016;4:e2667. DOI: 10.7717/peerj.266710.7717/peerj.2667513613427920951Open DOISearch in Google Scholar

7. Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865-77. DOI: 10.1016/j.jamcollsurg.2006.08.02610.1016/j.jamcollsurg.2006.08.02617116555Open DOISearch in Google Scholar

8. Poole L, Kidd T, Leigh E, Ronaldson A, Jahangiri M, Steptoea A. Depression, C-reactive protein and length of post-operative hospital stay in coronary artery bypass graft surgery patients. Brain Behav Immun. 2014;37(100):115-21. DOI: 10.1016/j.bbi.2013.11.00810.1016/j.bbi.2013.11.008396958924239712Search in Google Scholar

9. Holmes JH 4th, Connolly NC, Paull DL, Hill ME, Guyton SW, Ziegler SF, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res. 2002;51(12):579-86. DOI: 10.1007/PL0001243210.1007/PL00012432Open DOISearch in Google Scholar

10. Royston D. Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass. J Cardiovasc Pharmacol. 1996;27(Suppl. 1):S42-9. DOI: 10.1097/00005344-199600001-0001010.1097/00005344-199600001-000108938283Search in Google Scholar

11. Cernea S, Şular FL, Huţanu A, Voidăzan S. Markers of cognitive impairment in patients with type 2 diabetes. Rev Rom Med Lab. 2016;24(2):161-76. DOI: 10.1515/rrlm-2016-002310.1515/rrlm-2016-0023Open DOISearch in Google Scholar

12. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994;108(4):626-35.10.1016/S0022-5223(94)70286-1Search in Google Scholar

13. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(10):3542-8. DOI: 10.1161/01.CIR.96.10.354210.1161/01.CIR.96.10.3542Search in Google Scholar

14. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattier BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-9. DOI: 10.1126/science.163156010.1126/.1631560Open DOISearch in Google Scholar

15. Van Zee KJ, Fischer E, Hawes AS, Hébert CA, Terrell TG, Baker JB, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol. 1992;148(6):1746-52.10.4049/jimmunol.148.6.1746Search in Google Scholar

16. Mitchell JD, Grocott HP, Phillips-Bute B, Mathew JP, Newman MF, Bar-Yosef S. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine. 2007;38(1):37-42. DOI: 10.1016/j.cyto.2007.04.00910.1016/j.cyto.2007.04.00917572096Open DOISearch in Google Scholar

17. Metinko A, Kunkel S, Standiford T, Streter R. Monocyte expression of interleukin-8 in response to oxidant stress. FASEB J Abstracts Part 1. 1991:1941;A704 (Abstract).Search in Google Scholar

18. Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J. 2012;164(5):779-85. DOI: 10.1016/j.ahj.2012.05.02710.1016/j.ahj.2012.05.02723137510Open DOISearch in Google Scholar

19. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardio-pulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993;40(11):1016-21. DOI: 10.1007/BF0300947010.1007/BF030094708269560Search in Google Scholar

20. Wu ZK, Laurikka J, Vikman S, Nieminen R, Moilanen E, Tarkka MR. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J Surg. 2008;32(12):2643-9. DOI: 10.1007/s00268-008-9758-710.1007/s00268-008-9758-718850246Open DOISearch in Google Scholar

21. Kirklin, JW, Barratt-Boyes, BG. Hypothermia, circulatory arrest, and cardiopulmonary bypass. In: Cardiac surgery. 2nd ed. Churchill Livingstone, New York; 1993: 61-128.Search in Google Scholar

22. Gurbuz O, Kumtepe G, Ercan A, Yolgosteren A, Ozkan H, Karal IH, et al. A comparison of off- and on-pump beating-heart coronary artery bypass surgery on long-term cardiovascular events. Cardiovasc J Afr. 2017;28(1):30-5. DOI: 10.5830/CVJA-2016-04910.5830/CVJA-2016-049542343327172146Open DOISearch in Google Scholar

23. Wang J, Yu W, Zhao D, Liu N, Yu Y. In-hospital and long-term mortality in 35,173 Chinese patients undergoing coronary artery bypass grafting in Beijing: impact of sex, age, myocardial infarction, and cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2017;31(1):26-31. DOI: 10.1053/j.jvca.2016.08.00410.1053/j.jvca.2016.08.00427771273Open DOISearch in Google Scholar

24. Takagi H, Umemoto T. All-Literature Investigation of Cardiovascular Evidence (ALICE) Group: Worse long-term survival after off-pump than on-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;148:1820-9. DOI: 10.1016/j.jtcvs.2014.05.03410.1016/j.jtcvs.2014.05.034Open DOISearch in Google Scholar

25. Mathison M, Edgerton JR, Horswell JL, Akin JJ, Mack MJ. Analysis of hemodynamic changes during beating heart surgical procedures. Ann Thorac Surg. 2000;70:1355-60. DOI: 10.1016/S0003-4975(00)01590-310.1016/S0003-4975(00)01590-3Open DOISearch in Google Scholar

26. Göber V, Hohl A, Gahl B, Dick F, Eigenmann V, Carrel TP, et al. Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery. PLoS One. 2013;8(9):e74241. DOI: 10.1371/journal.pone.007424110.1371/journal.pone.0074241Search in Google Scholar

27. Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Müller-Bardorff M, et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2004;50(9):1560-7. DOI: 10.1373/clinchem.2004.03146810.1373/clinchem.2004.031468Open DOISearch in Google Scholar

28. Kathiresan S, Servoss SJ, Newell JB, Trani D, Mac-Gillivray TE, Lewandrowski K, et al. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol. 2004;94(7):879-81. DOI: 10.1016/j.amj-card.2004.06.02210.1016/j.amj-card.2004.06.022Open DOISearch in Google Scholar

29. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg. 2000;69(2):435-40. DOI: 10.1016/S0003-4975(99)01294-110.1016/S0003-4975(99)01294-1Open DOISearch in Google Scholar

30. Mukaida N, Shiroo M, Matsusima K. Genomic structure of the human monocyte-derived neutrophil chemo-tactic factor IL-8. J Immunol. 1989;143:1366-71.10.4049/jimmunol.143.4.1366Search in Google Scholar

31. Standiford TJ, Strieter RM, Chensue SI, Westwick J, Kasahara K, Kunkel SL. IL-4 inhibits the expression of IL-8 from stimulated monocytes. J Immunol. 1990;145:1435-9.10.4049/jimmunol.145.5.1435Search in Google Scholar